Table 2.
Odds Ratios for Breast Cancer by Tertile of Human Chorionic Gonadotropin and α-Fetoprotein Concentrations in Pregnancy, Northern Sweden Maternity Cohort, 1975–2001
Tertile |
P-Trend | |||||||||||
1 |
2 |
3 |
||||||||||
OR | No. of Cases | No. of Controls | OR | 95% CI | No. of Cases | No. of Controls | OR | 95% CI | No. of Cases | No. of Controls | ||
Human Chorionic Gonadotropina | ||||||||||||
All women | 1.00 | 63 | 98 | 1.03 | 0.63, 1.69 | 61 | 98 | 0.86 | 0.52, 1.42 | 49 | 98 | 0.54 |
Age at sampling, years | ||||||||||||
<30 | 1.00 | 30 | 45 | 0.92 | 0.44, 1.92 | 27 | 45 | 0.77 | 0.37, 1.61 | 22 | 45 | 0.49 |
≥30 | 1.00 | 31 | 53 | 1.19 | 0.63, 2.24 | 36 | 53 | 0.91 | 0.46, 1.81 | 27 | 53 | 0.84 |
Parity | ||||||||||||
Primiparous | 1.00 | 35 | 44 | 0.68 | 0.32, 1.44 | 21 | 44 | 0.68 | 0.33, 1.41 | 22 | 45 | 0.29 |
Multiparous | 1.00 | 34 | 53 | 0.817 | 0.46, 1.66 | 31 | 54 | 0.92 | 0.48, 1.75 | 30 | 54 | 0.78 |
Lag time to diagnosis, yearsb | ||||||||||||
<14 | 1.00 | 21 | 47 | 2.20 | 0.95, 5.10 | 35 | 48 | 1.67 | 0.72, 3.86 | 26 | 48 | 0.25 |
≥14 | 1.00 | 41 | 50 | 0.58 | 0.30, 1.15 | 27 | 50 | 0.53 | 0.27, 1.03 | 23 | 51 | 0.06 |
Age at cancer diagnosis, years | ||||||||||||
<45 | 1.00 | 31 | 50 | 1.25 | 0.63, 2.46 | 33 | 50 | 0.82 | 0.40, 1.70 | 24 | 51 | 0.66 |
≥45 | 1.00 | 34 | 47 | 0.71 | 0.35, 1.44 | 26 | 48 | 0.72 | 0.36, 1.44 | 25 | 48 | 0.36 |
Nonsmoker at blood donation | 1.00 | 38 | 43 | 0.68 | 0.33, 1.38 | 25 | 43 | 0.73 | 0.37, 1.44 | 26 | 44 | 0.33 |
α-Fetoprotein | ||||||||||||
Full data set | 1.00 | 67 | 116 | 1.08 | 0.67, 1.73 | 73 | 116 | 0.91 | 0.55, 1.50 | 64 | 117 | 0.63 |
Restricted datac | 1.00 | 54 | 99 | 1.21 | 0.75, 1.95 | 66 | 99 | 0.96 | 0.58, 1.58 | 54 | 99 | 0.80 |
Abbreviations: CI, confidence interval; OR, odds ratio.
All models for human chorionic gonadotropin were adjusted for smoking.
Test for homogeneity of results below and above the median lag time to cancer diagnosis: P = 0.10.
Women who donated blood before January 1, 1988 (174 cases and 297 controls).